<DOC>
	<DOCNO>NCT00192257</DOCNO>
	<brief_summary>- Trial ass asthma exacerbation end study ; demonstrate efficacy one season culture-confirmed influenza-illness ; finally ass safety tolerability CAIV-T child asthma .</brief_summary>
	<brief_title>Trial Compare Safety , Tolerability Efficacy Influenza Virus Vaccine , ( CAIV-T ) With Influenza Virus Children With Asthma</brief_title>
	<detailed_description>- To assess asthma exacerbation , define acute wheeze illness associate hospitalization , unscheduled clinic visit , new prescription study vaccination end study .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Influenza , Human</mesh_term>
	<criteria>age least 6 year 17 year age time enrollment ; clinical diagnosis asthma one follow criterion : An International Classification Diseases , Ninth revision ( ICD9 ) code 493 AND ≥one prescription asthma medication ; OR ≥one prescription inhale betaagonist ≥one prescription cromolyn ; OR ≥Five prescription asthma medication ( adapt Kramarz et al,2000 Osborne et al. , 1995 ) 1,2 ; asthma medication* define : inhaled oral β agonist theophyllin inhale , oral injected steroid unclassified asthma medication antibiotic use treatment respiratory illness associate wheezing episode ; least one asthma medication administer last 12 month , female postmenarche , provide negative pregnancy test prior study vaccination ; provide write informed consent ( appropriate accord national guideline ) whose parent ( ) /legal guardian ( ) provide write informed consent nature study explain ; , along parent ( ) /legal guardian ( ) , available duration trial ; who/whose parent ( ) /legal guardian ( ) , reach study staff postvaccination contact [ telephone , clinic home visit ] . who/whose parent ( ) /legal guardian ( ) perceive unavailable difficult contact evaluation study visit study period ; serious chronic disease ( e.g. , sign cardiac renal failure severe malnutrition ) , include progressive neurological disease ; Down 's syndrome know cytogenetic disorder ; know suspected disease immune system receive immunosuppressive therapy , include systemic corticosteroid dose equivalent total 20 mg/day great prednisolone equivalent , 14 day duration 2 week corticosteroid discontinue 25 ; receive blood product , include immunoglobulin , period six month prior vaccination conclusion study ; intent administer investigational vaccine agent one month prior enrollment conclusion study ; immunosuppressed immunocompromised individual living household ; receive influenza vaccine 6 month prior enrollment , anticipate receive nonstudy influenza vaccine enrollment ; document history hypersensitivity egg egg protein component CAIVT TIV ; receive aspirin ( acetylsalicylic acid ) aspirincontaining product two week prior enrollment use anticipate study ; medical condition opinion investigator might interfere interpretation study result ; Note : Pregnancy person regular contact subject contraindication enrollment ongoing participation subject study .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>October 2006</verification_date>
</DOC>